Skip to main content
. 2024 Jan 3;4(1):1–8. doi: 10.21873/cdp.10278

Table II. Response assessment in Response Evaluation Criteria for Solid Tumors (RECIST) 1.1, immune-related response criteria (irRC), immunerelated RECIST (irRECIST) and immune RECIST (iRECIST). Adapted and reproduced from (6, 18, 35).

graphic file with name cdp-4-4-i0001.jpg

FDG PET: Fluorodeoxyglucose positron-emission tomography; iCPD: ‘immune’ response (by iRECIST) confirmed progressive disease; iUPD: ‘immune’ response (by iRECIST) unconfirmed progressive disease.